OmniGuide Surgical said it raised a $15 million funding round for its BeamPath surgical layer. The Cambridge, Mass.-based medical device company said it plans to use the round to expand BeamPath's footprint in the gynecological market and launch new ear, nose & throat products.
During a Formula 1 race, a car sends hundreds of millions of data points to its garage for real-time analysis and feedback. So why not use this detailed and rigorous data system elsewhere, like ... at children’s hospitals?
Inova Translational Medicine Institute and GNS Healthcare Partner To Advance Diagnosis and Prevention of Preterm BirthAugust 8, 2013 8:01 am | by PRNewswire | News | Comments
The Inova Translational Medicine Institute (ITMI) at Inova Fairfax Hospital and GNS Healthcare today announced a partnership to develop and commercialize computer models capable of predicting risk of preterm live birth, built using next generation sequencing and electronic medical record data.
Welch Allyn Aims to Improve Patient Comfort and Safety with Acrylic Vaginal Specula and Cordless Illumination SystemAugust 1, 2013 1:27 pm | by Welch Allyn | News | Comments
Welch Allyn, a leading medical diagnostic device company that specializes in helping clinicians improve patient outcomes, today announced a new promotion designed to help women’s health providers improve patient comfort and safety with its disposable KleenSpec® Vaginal Specula and Welch Allyn Cordless Illumination System.
As many as 20 percent of infertile couples in the United States have unexplained reasons for their infertility. Now, new research led by Catherine Racowsky, PhD, director of the Assisted Reproductive Technologies Laboratory at Brigham and Women's Hospital, shows that exposure to BPA could be a contributing factor as to why some infertile couples are having difficulty conceiving.
Guided Therapeutics and I.T.E.M. Medical Technologies Group Announce Turkish Ministry of Health Sponsored Cervical Cancer Prevention Program Involving the LuViva® Advanced Cervical ScanJuly 2, 2013 8:29 am | by Business Wire | News | Comments
NORCROSS, Ga. & ANKARA, Turkey--(BUSINESS WIRE)--Jul 2, 2013--First graph, second sentence should read: The program for 2013 and 2014, to be funded by Turkey’s Ministry of Health (sted The program for 2013 and 2104). The corrected release reads: GUIDED THERAPEUTICS AND...
As more therapies are able to indicate implantable devices for treatment, incorporating drug delivery into them can be a significant additional benefit. Even when drug delivery is the primary function, implantable devices can be preferable. This article reviews some representative applications that device designers can leverage in developing new products for the implantable drug delivery market.
Soon, women in Europe may be taking a new look at one of the world’s oldest forms of contraception. European regulators have granted the single-size SILCS Diaphragm a CE marking, allowing the product to be sold throughout Europe. The launch is also an important step toward expanding nonhormonal contraception options for women worldwide.
Two Johns Hopkins gynecologic surgeons are among the first in the nation to perform a robotic hysterectomy using a single, small incision. Amanda Nickles Fader, M.D. and Stacey Scheib, M.D. recently performed several other types of single-site robotic gynecologic procedures—including surgery for fibroids, abnormal uterine bleeding, and ovarian cysts and masses.
Unique energy-based surgical devices afford broad clinical use in the cutting, coagulation, and ablation of tissues using a high velocity jet of thermal plasma, and the PlasmaJet surgical system is one example of this medical device evolution. Plasma is formed when sufficient energy is added to remove outer electrons from a gas to form ions.
Going Under the Knife—Millions of Americans will have surgery this year. Whether it’s the result of an emergency, an exploratory procedure, or even elective, some surgical procedures are more common depending on your age. An infographic by the team at Top Surgeries Graphic - CompHealth.
German drug company Bayer AG says it has agreed to buy California-based Conceptus for around $1.1 billion to expand the kinds of birth control it offers. Bayer said Monday it would launch a public offer to pay $31.00 per share for all the stock in Conceptus, Inc., which is based in Mountain View.
Intuitive Surgical shares suffered a sudden sell-off today after the American Congress of Obstetricians & Gynecologists released a statement questioning some of the marketed benefits of robot-assisted surgery. ACOG president Dr. James Breeden issued a statement warning that the benefits of robot-assisted surgery may also be achieved through other minimally invasive methods.
LIVERMORE, Calif., March 12, 2013 /PRNewswire/ -- Halt Medical, Inc. announced that Dr. Jay M. Berman, M.D., FACOG, has performed the first commercial Acessa Procedure in the United States. The procedure is used for the treatment of uterine fibroids. Dr. Berman performed the procedure at...
Global Gynecological Devices Market is Expected to Reach USD 5.3 Billion by 2018: Transparency Market ResearchMarch 6, 2013 4:36 am | by Bio-Medicine.Org | News | Comments
As per the new market report published by Transparency Market Research "Gynecological Devices Market (Surgical Devices, Endometrial Ablation Devices, Female Sterilization and Contraception Devices, Vaginal Speculum, Tenaculum, Biopsy Forceps, Diagnostic Imaging Systems and Gynecological...
Halt Medical, Inc. announced today that on January 18, 2013, COFEPRIS, a division within the Mexican Ministry of Health (Secretaria de Salud) responsible for medical device oversight, issued registration for the Acessa System to treat symptomatic uterine fibroids. "Mexico is the second...
Conceptus Announces Enrollment of First Patient in European Clinical Trial for Next Generation EssureFebruary 5, 2013 11:34 am | by GlobeNewswire | News | Comments
Conceptus, Inc., developer of the Essure® procedure, the leading surgery-free permanent birth control method, announced today that it has initiated enrollment in its European clinical study designed to support the company's CE Mark application for its next generation Essure device.
Pushing the limits of gynecologic endoscopy, Richard Wolf Medical Instruments Corp. introduces the 3.8 mm Compact Hysteroscope, an exceptionally happy marriage of patient comfort and physician versatility. “We are excited about the launch of this product because it is truly unique...
GE Healthcare Integrates Covidien Nellcor SpO2 with OxiMax Technology and SatSeconds Alarm Management System into Giraffe and Panda Infant WarmersDecember 11, 2012 2:56 pm | News | Comments
Covidien, a leading global provider of healthcare products and recognized innovator in patient monitoring and respiratory care devices, today announced the integration of its industry-leading Nellcor™ pulse oximetry with OxiMax™ technology into GE Healthcare Giraffe® and Panda® infant warmers.
The only way to protect against HIV and unintended pregnancy today is the condom. It's an effective technology, but not appropriate or popular in all situations. A University of Washington team has developed a versatile platform to simultaneously offer contraception and prevent HIV.
The Medical College of Wisconsin (MCW) has begun a clinical study of InTone®, a new, FDA-approved medical device that treats female urinary incontinence. The 12-week study will evaluate the effectiveness of InTone in women with stress incontinence, urge incontinence, or mixed (stress AND urge) incontinence.
Today Personal Medical Corp. (“Personal Med”) was officially launched as an independent medical device company focusing on advances in women’s pelvic health. The company was previously a wholly owned subsidiary of SRS Medical in Billerica MA.
BLOOMINGTON, Ind.--(BUSINESS WIRE)--Cook Medical's Cervical Ripening Balloon will now be available with a guiding stylet that offers added stiffness to facilitate placement when conditions for inducing labor are unfavorable. The addition of a stylet helps obstetricians position the balloon...
Tweet • Results based on lower-cost MRI screenings for high-risk, uninsured or under-insured women.• MRI screenings found more cancer cases in high-risk women than mammography.• Underserved women can benefit from...
Johnson & Johnson Makes Strong Progress in First Year of Initiative to Improve Health of Millions of Women and Children in the Developing WorldSeptember 20, 2011 8:37 am | by Bio-Medicine.Org | News | Comments
NEW BRUNSWICK, N.J., Sept. 20, 2011 /- Johnson & Johnson (NYSE: JNJ ) today announced important progress made in the inaugural year of the Company's comprehensive effort designed to improve the health of as many as 120 million women and children each year in developing countries by...